Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the combination of topotecan, cisplatin and
bevacizumab is effective in the treatment of recurrent or persistent cervical cancer